| Zacks Brokerage Buy List: CVS Corporation, Eli Lilly, QUALCOMM and Exxon Mobil Corporation |
|
|
|
| Friday, 04 November 2005 | |
Zacks Brokerage Buy List: CVS Corporation, Eli Lilly, QUALCOMM and Exxon Mobil CorporationCHICAGO, IL, (NAMC) - Today Zacks.com releases the names of four more stocks that are on their coveted Brokerage Buy List portfolio. This portfolio includes just those stocks that currently appear on the core recommended lists of at least three of the top 14 brokerage firms. These stocks are considered the best large-cap stocks to own for the long-term according to Wall Street's top players. Since January 2003, this portfolio has generated an annualized double-digit return. Here are four stocks that are currently members of this prestigious list: CVS Corporation (NYSE:CVS), Eli Lilly (NYSE:LLY), QUALCOMM, Inc. (NASDAQ:QCOM) and Exxon Mobil Corporation (NYSE:XOM). View the entire list of stocks on the Brokerage Buy List at http://at.zacks.com/?id=139 Here are explanations as to why these stocks are on the Brokerage Buy List: CVS Corporation (NYSE:CVS) recently reported total sales for October of $2.8 billion, marking a 7.8% year-over-year advanced from $2.6 billion. Total pharmacy sales accounted for 70.9% of total company sales. Same-store sales for the month advanced 5.6%. CVS Corporation, which remains a large-cap stocks to own for the long term by three leading brokerages, also reported third quarter results on Thursday, which including earnings per share that advanced year-over-year. For the quarter, net sales advanced 13.4% to $9 billion while same-store sales increased 5.7%. The company said that the third quarter was very solid in its core business as well as its acquired stores. Eli Lilly (NYSE:LLY) is considered one of the best large cap stocks to own for the long term by three of the leading brokerages. Last month, the company reported a strong third quarter performance, which included earnings per share of 73 cents that improved year-over-year by 6% from 69 cents. That result was also almost 3% ahead of the consensus. Meanwhile, worldwide sales reached $3.6 billion, marking an advanced of 10% year-over-year, as newer products accounted for 18% of total sales. In the third quarter 2004, newer products accounted for 12% of total sales. Eli Lilly stated that, as expected, the second half of 2005 is bringing stronger sales and earnings growth as the company continues to improve productivity and deliver on the promise of its portfolio. QUALCOMM, Inc. (NASDAQ:QCOM) stated that its record financial results reflect the accelerating migration to CDMA throughout the world. For its fiscal fourth quarter, the company posted revenues of $1.56 billion, marking advances of 40% and 15% on a year-over-year and sequential basis respectively. Furthermore, earnings per share of 32 cents marked a rise from the previous year. As of September 2005, QUALCOMM said there were about 159 operators offering third generation services in 71 countries with more than 200 million subscribers. The company expects 2006 to be another strong growth year with new CDMA handset shipments growing by about 30%. Three of the top brokerage firms believe that QUALCOMM is a solid large-cap company for the long term. Exxon Mobil Corporation (NYSE:XOM) felt an impact from the hurricanes, but it didn't keep the company from reporting the largest quarterly profit in U.S. history with third quarter net income of $9.92 billion. Excluding items, earnings per share reached $1.32 for the quarter, which fell short of the consensus by still marked a solid year-over-year advance. The company said its earnings reflect the impact of the relatively volatile industry environment on commodity prices and industry margins. Revenue advanced to $100.72 billion from $76.38 billion year-over-year. Exxon Mobil is considered on of the best large-cap stocks to own for the long-term by as many as five of the leading brokerage firms. To discover all the other profitable stock portfolios at Zacks.com, use this link: http://at.zacks.com/?id=140 About Zacks Brokerage Buy List Zacks has developed many successful ways for individual investors to profit from the stock picking prowess of Wall Street professionals. The Brokerage Buy List is yet another powerful tool that investors can wield in order to improve their investment results. This portfolio is comprised of the core stocks recommended by at least three of the Top 14 brokerage firms. These are the kind of large cap stocks that are best for long- term investors. Since January 2003, this portfolio has generated an annualized double-digit return. To learn more about the Brokerage Buy List, go to http://at.zacks.com/?id=141 About Zacks Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 to compile, analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind Zacks work is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. The goal is to unlock these pros' profitable insights for individual investors hard-pressed to find this valuable information in one source. A free subscription to "Profit from the Pros" weekly e-mail newsletter provides the best way to use these experts' insights for more profitable investing. Register for a free subscription to the Profit from the Pros newsletter at http://at.zacks.com/?id=142 Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. (a)The S&P 500 Index ("S&P 500") is a well-known, unmanaged index of the prices of 500 large-company common stocks selected by Standard and Poor's. The S&P 500 includes the reinvestment of all dividends, no transaction costs, and represents the gross returns before management fees. Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. Contact: |
